2007 43th ASCO Annual Meeting - účast ČR

Breast Cancer--Metastatic Breast Cancer

Efficacy of oral vinorelbine (NVBo), capecitabine (X) and trastuzumab (H) triple combination (NVBoXH) in HER2-positive metastatic breast cancer (MBC): First results of an international phase II trial.

Autoři: A. T. C. Chan; V. Ganju; D. Becquart; P.F. Conte; prof. MUDr. Luboš Petruželka, CSc.; D. Aubert; G. Villanova; N. Tubiana-Mathieu
Číslo abstraktu: 1052
Kategorie: Zhoubné nádory prsu

Gastrointestinal (Colorectal) Cancer

Validation of sentinel lymph node (SLN) mapping (M) in colon cancer (Cca) over three continents: An international experience.

Autoři: S. Saha; M. Patel; A. Bilchik; T. Beutler; M. Zuber; A. Bembenek; Y. Kitagawa; MUDr. Jiří Duben, Ph.D.; C. Codignola; G. Cserni
Číslo abstraktu: 4047
Kategorie: Gastrointestinální nádory

Leukemia, Myelodysplasia and Transplantation

Impact of prognostic factors on outcome in a phase III study comparing alemtuzumab to chlorambucil as first-line therapy for B-cell chronic lymphocytic leukemia (BCLL).

Autoři: prof. MUDr. Jiří Mayer, CSc.; MD Tadeusz Robak, PhD.; Aleksander Skotnicki; Branimir Jaksic; Anna Dmoszynska; Cynthia Sirard; Peter Hillmen, M.B. ChB, Ph.D.
Číslo abstraktu: 7035
Kategorie: Maligní lymfomy a leukémie

Lung Cancer

Phase III study of vinflunine versus docetaxel in patients (pts) with advanced non-small cell lung cancer (NSCLC) previously treated with a platinum-containing regimen.

Autoři: M. Krzakowski; J. Douillard; Rodryg Ramlau; prof. dr hab. n. med. Jacek Jassem; Aleksandra Szczesna; prof. MUDr. Petr Zatloukal (1955-2012), CSc.; J. von Pawel; O. Hansen; X. Sun
Číslo abstraktu: 7511
Kategorie: Zhoubné nádory plic a průdušek

Randomised, double-blind multicentre phase III study of bevacizumab in combination with cisplatin and gemcitabine in chemotherapy-naďve patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): BO17704

Autoři: C. Manegold; J. von Pawel; prof. MUDr. Petr Zatloukal (1955-2012), CSc.; Rodryg Ramlau; V. Gorbounova; MD Vera Hirsh; N. B. Leighl; J. Mezger; Venice Archer; M. Reck; the BO17704 study group
Číslo abstraktu: LBA7514
Kategorie: Zhoubné nádory plic a průdušek

Pemetrexed in advanced non-small cell lung cancer: A randomized trial of 500 mg/m2 vs 900 mg/m2 in 588 patients who progressed after platinum-containing chemotherapy

Autoři: M. H. Cullen; prof. MUDr. Petr Zatloukal (1955-2012), CSc.; S. Sörenson; S. Novello; J. R. Fischer; A. Joy; M. Zereu; P. Peterson; C. Visseren-Grul; N. Iscoe
Číslo abstraktu: LBA7727
Kategorie: Zhoubné nádory plic a průdušek

Lymphoma and Plasma Cell Disorders

Revalidation of FLIPI in patients with follicular lymphoma (FL) registered in the F2 study and treated upfront with immunochemotherapy.

Autoři: Prof. M.D. Massimo Federico; M. Bellei; B. Pro; MD Armando Lopez-Guillermo; L. Marcheselli; Prof. MUDr. Marek Trněný, CSc.; Pierre Soubeyran; P. McLaughlin; Stefano Pileri; P. Solal-Céligny
Číslo abstraktu: 8008
Kategorie: Maligní lymfomy a leukémie

Tumor Biology and Human Genetics

Receptor for advanced glycation end-products (RAGE) - soluble form (sRAGE) and gene polymorphisms in patients with breast cancer.

Autoři: prof. MUDr. Petra Tesařová, CSc.; Marta Kalousova; M. Jachymova; Ing. Oto Mestek, CSc.; prof. MUDr. Luboš Petruželka, CSc.; prof. MUDr. Tomáš Zima, DrSc., MBA
Číslo abstraktu: 21113
Kategorie: Nádorová biologie/imunologie/genetika a buněčná terapie